Dymista Allergen Chamber - Onset of Action Study

Summary

This study is to assess the onset of action of fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray (Dymista) in treating the nasal symptoms of seasonal allergic rhinitis (SAR) induced by an allergen challenge in an Environmental Exposure Unit (EEU).

Timeline

Start

2020-12-14

Primary completion

2021-12-04

Completion

2021-12-13

Drugs

Indications